Bryan Dechairo | Source | President, CEO at Sherlock Biosciences
Bryan Dechairo
Bryan is the President and Chief Executive Officer at Sherlock Biosciences. He is a dynamic and results-driven molecular diagnostic R&D and business executive with a proven track record of funding and scaling business from venture backed start-ups to profitable fortune 50 public companies. Bryan is a passionate C-suite officer with over 20 years of experience spanning research to commercial, inventing, developing, and commercializing revenue generating clinical innovations that improve patient lives.
-
This is a great milestone for people who want access to diagnostics wherever they are, whether in low- and middle-income countries or the United States.
-
Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics
Sherlock Biosciences has bought global molecular diagnostics company Sense Biodetection to make next-generation diagnostics.
Article
-
Sherlock Biosciences
President, CEO